THE PROMISING POTENTIAL OF PCSK9 INHIBITORS AND INTENSIVE STATIN THERAPY IN ADDRESSING INTRACRANIAL ATHEROSCLEROSIS-A PILOT STUDY

被引：0
|
作者：
Tan, Z. [1 ]
Chen, G. [2 ]
Zeng, W. [1 ]
Yan, B. [3 ]
机构：
[1] First Peoples Hosp Foshan Guangdong China, Dept Neurol, Foshan, Peoples R China
[2] First Peoples Hosp Foshan, Deans Off, Foshan, Peoples R China
[3] Royal Melbourne Hosp, Neurol, Melbourne, Vic, Australia
来源：
INTERNATIONAL JOURNAL OF STROKE | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O290
引用
收藏
页码：127 / 127
页数：1
相关论文
共 27 条
  • [1] A promising therapy for fatty liver disease: PCSK9 inhibitors
    Han, Lizhu
    Wu, Liuyun
    Yin, Qinan
    Li, Lian
    Zheng, Xingyue
    Du, Shan
    Huang, Xuefei
    Bai, Lan
    Wang, Yi
    Bian, Yuan
    PHYTOMEDICINE, 2024, 128
  • [2] PCSK9 inhibitors: an overview on a new promising lipid-lowering therapy
    Denegri, Andrea
    Petrova-Slater, Iveta
    Pasotti, Elena
    Rossi, Maria Grazia
    Pedrazzini, Giovanni Battista
    Moccetti, Tiziano
    Moccetti, Marco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (04) : 237 - 244
  • [3] Role of PCSK9 Inhibitors in Acute Coronary Syndromes - A Pilot Study
    Abdelnabi, Mahmoud
    Benjanuwattra, Juthipong
    Saleh, Yehia
    Del Rio-Pertuz, Gaspar
    Leelaviwat, Natnicha
    Almaghraby, Abdallah
    CIRCULATION, 2022, 146
  • [4] Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study
    Wu, Lingshan
    Kong, Qianqian
    Huang, Hao
    Xu, Shabei
    Qu, Wensheng
    Zhang, Ping
    Yu, Zhiyuan
    Luo, Xiang
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [5] ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model
    Hurt-Camejo, Eva
    JOURNAL OF LIPID RESEARCH, 2020, 61 (03) : 272 - 274
  • [6] COMBINATION OF INTENSIVE STATINS AND PCSK9 INHIBITORS INCREASES THE STABILITY OF INTRACRANIAL ARTERY PLAQUES: A PROSPECTIVE SINGLE-ARM STUDY
    Zeng, W.
    Tan, Z.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 85 - 85
  • [7] PCSK9 Inhibitor with Statin Therapy for Intracranial Artery Stenosis ( PISTIAS): Rationale and design of a multicenter randomized controlled trial
    Hu, Xinzhi
    Zhang, Zongmuyu
    Liu, Caiyan
    Li, Mingli
    Liu, Yiyang
    Cheng, Anqi
    Yu, Qiuyu
    Guo, Haoyao
    Zou, Yinxi
    Zhou, Li
    Wang, Hebo
    Song, Bo
    You, Yong
    Xia, Jian
    Zhang, Jingfen
    Ai, Zhibing
    Sun, Qinjian
    Han, Ju
    Liu, Jing
    Lu, Baoquan
    Deng, Qiwen
    Li, Guanzeng
    Wang, Peng-fei
    Li, Xiangqing
    An, Yi
    Wu, Bo
    Yan, Zhongrui
    Wang, Yining
    Xu, Wei-Hai
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (09) : 1071 - 1076
  • [8] COST EFFECTIVENESS OF INTENSIVE LOWERING OF LDL CHOLESTEROL WITH PCSK9 INHIBITORS AS AN ADJUNCT TO HIGH-INTENSITY STATIN THERAPY FOR PREVENTION OF MAJOR VASCULAR EVENTS
    Lee, H.
    Watkins, J.
    Danielson, D.
    VALUE IN HEALTH, 2016, 19 (03) : A48 - A48
  • [9] PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis
    Khan, Safi U.
    Yedlapati, Siva H.
    Lone, Ahmad N.
    Hao, Qiukui
    Guyatt, Gordon
    Delvaux, Nicolas
    Bekkering, Geertruida E.
    Vandvik, Per Olav
    Bin Riaz, Irbaz
    Li, Sheyu
    Aertgeerts, Bert
    Rodondi, Nicolas
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [10] PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis
    Khan, Safi U.
    Yedlapati, Siva H.
    Lone, Ahmad N.
    Hao, Qiukui
    Guyatt, Gordon
    Delvaux, Nicolas
    Bekkering, Geertruida E.
    Vandvik, Per Olav
    Bin Riaz, Irbaz
    Li, Sheyu
    Aertgeerts, Bert
    Rodondi, Nicolas
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
123